Trends in Thoracic Impedance and Arrhythmia Burden Among Patients with Implanted Cardiac Defibrillators During the COVID-19 Pandemic.
Daisy S MasseyKarthik MurugiahPaul W JonesCesar CaraballoShiwani MahajanDaisy S MasseyRezwan AhmedEric M BaderHarlan M KrumholzPublished in: medRxiv : the preprint server for health sciences (2021)
Hospitalizations for acute cardiac conditions have markedly declined during the coronavirus disease 2019 (COVID-19) pandemic, yet the cause of this decline is not clear. Using remote monitoring data of 4,029 patients with implantable cardiac defibrillators (ICDs) living in New York City and Minneapolis/Saint Paul, we assessed changes in markers of cardiac status among these patients and compared thoracic impedance and arrhythmia burden in 2019 and 2020 from January through August. We found no change in several key disease decompensation markers among patients with implanted ICD devices during the first phase of COVID-19 pandemic, suggesting that the decrease in cardiovascular hospitalizations in this period is not reflective of a true population-level improvement in cardiovascular health.
Keyphrases
- left ventricular
- coronavirus disease
- end stage renal disease
- spinal cord
- ejection fraction
- chronic kidney disease
- heart failure
- cardiac resynchronization therapy
- liver failure
- magnetic resonance imaging
- risk factors
- peritoneal dialysis
- spinal cord injury
- intensive care unit
- respiratory failure
- sars cov
- patient reported outcomes
- drug induced
- data analysis
- aortic dissection
- dual energy
- atrial fibrillation